Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'
- PMID: 28735775
- PMCID: PMC5577861
- DOI: 10.1016/j.drugpo.2017.06.004
Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'
Abstract
Background: The US is experiencing an unprecedented opioid overdose epidemic fostered in recent years by regional contamination of the heroin supply with the fentanyl family of synthetic opioids. Since 2011 opioid-related overdose deaths in the East Coast state of Massachusetts have more than tripled, with 75% of the 1374 deaths with an available toxicology positive for fentanyl. Fentanyl is 30-50X more potent than heroin and its presence makes heroin use more unpredictable. A rapid ethnographic assessment was undertaken to understand the perceptions and experiences of people who inject drugs sold as 'heroin' and to observe the drugs and their use.
Methods: A team of ethnographers conducted research in northeast Massachusetts and Nashua, New Hampshire in June 2016, performing (n=38) qualitative interviews with persons who use heroin.
Results: (1) The composition and appearance of heroin changed in the last four years; (2) heroin is cheaper and more widely available than before; and (3) heroin 'types' have proliferated with several products being sold as 'heroin'. These consisted of two types of heroin (alone), fentanyl (alone), and heroin-fentanyl combinations. In the absence of available toxicological information on retail-level heroin, our research noted a hierarchy of fentanyl discernment methods, with embodied effects considered most reliable in determining fentanyl's presence, followed by taste, solution appearance and powder color. This paper presents a new 'heroin' typology based on users' reports.
Conclusion: Massachusetts' heroin has new appearances and is widely adulterated by fentanyl. Persons who use heroin are trying to discern the substances sold as heroin and their preferences for each form vary. The heroin typology presented is inexact but can be validated by correlating users' discernment with drug toxicological testing. If validated, this typology would be a valuable harm reduction tool. Further research on adaptations to heroin adulteration could reduce risks of using heroin and synthetic opioid combinations.
Keywords: Fentanyl; Heroin; Mortality; Opioids; Overdose; Qualitative research.
Copyright © 2017 Elsevier B.V. All rights reserved.
References
-
- Algren D Adam, Monteilh Carolyn P, Punja Mohan, Schier Joshua G, Belson Martin, Hepler Bradford R, Schmidt Carl J, Miller Corinne E, Patel Manish, Paulozzi Leonard J, Straetemans Masja, Rubin Carol. Fentanyl-associated Fatalities Among Illicit Drug Users in Wayne County, Michigan (July 2005–May 2006) Journal of Medical Toxicology. 2013;9(1):106–115. doi: 10.1007/s13181-012-0285-4. - DOI - PMC - PubMed
-
- Associated Press, AP. Illicit-Drug Use OK In ‘Safe’ Site Under Maryland Bill. [Last Modified February 17 2017];2017 http://baltimore.cbslocal.com/2017/02/17/illicit-drug-use-ok-in-safe-sit....
-
- Australian Injecting & Illicit Drug Users League, AIVL. Injecting Fentanyl - Minimising the Risks. Australia: 2013.
-
- Ayres William A, Starsiak Mary Jo, Sokolay Phil. The bogus drug: three methyl & alpha methyl fentanyl sold as “China White”. Journal of psychoactive drugs. 1981;13(1):91–93. - PubMed
-
- Centers for Disease Control and Prevention, US. Morbidity and Mortality Weekly Report. Centers for Disease Control & Prevention (CDC); 2008. Nonpharmaceutical Fentanyl-Related Deaths — Multiple States, April 2005–March 2007. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
